UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 205

Sortiert nach

Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal

Oncogene, 2007-02, Vol.26 (8), p.1213-1221

2007

Volltextzugriff (PDF)

Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy

British journal of cancer, 1994-06, Vol.69 (6), p.1083-1087

1994

Volltextzugriff (PDF)

Combination of photodynamic therapy (PDT) and melphalan in experimental tumors

International journal of radiation oncology, biology, physics, 1994-06, Vol.29 (3), p.463-466

1994

Volltextzugriff (PDF)

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Journal of clinical oncology, 2019-09, Vol.37 (26), p.2317-2328

2019

Volltextzugriff (PDF)

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

The lancet oncology, 2019-05, Vol.20 (5), p.636-648

2019

Volltextzugriff (PDF)

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach

Radiation oncology (London, England), 2024-03, Vol.19 (1), p.34-34, Article 34

2024

Volltextzugriff (PDF)

Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3095-3106

2020

Volltextzugriff (PDF)

Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non–Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2016-05, Vol.95 (1), p.505-516

2016

Volltextzugriff (PDF)

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Neuro-oncology (Charlottesville, Va.), 2020-09, Vol.22 (9), p.1262-1275

2020

Volltextzugriff (PDF)

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

Journal for immunotherapy of cancer, 2018-01, Vol.6 (1), p.5-5, Article 5

2018

Volltextzugriff (PDF)

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

The lancet oncology, 2021-06, Vol.22 (6), p.824-835

2021

Volltextzugriff (PDF)

Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma

BMC cancer, 2017-06, Vol.17 (1), p.434-11, Article 434

2017

Volltextzugriff (PDF)

A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients

International journal of radiation oncology, biology, physics, 2021-07, Vol.110 (4), p.1082-1089

2021

Volltextzugriff (PDF)

Clinic-based interventions for improving access to care: a good start

JNCI : Journal of the National Cancer Institute, 2024-06, Vol.116 (6), p.786-788

2024

Volltextzugriff (PDF)

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1188-1198

2015

Volltextzugriff (PDF)

Shared acquired genomic changes in zebrafish and human T-ALL

Oncogene, 2011-10, Vol.30 (41), p.4289-4296

2011

Volltextzugriff (PDF)

The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

Cancer cell, 2014-09, Vol.26 (3), p.319-330

2014

Volltextzugriff (PDF)

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

Annals of oncology, 2017-05, Vol.28 (5), p.996-1004

2017

Volltextzugriff (PDF)

The primary cilium in cell signaling and cancer

Cancer research (Chicago, Ill.), 2006-07, Vol.66 (13), p.6463-6467

2006

Volltextzugriff (PDF)

Cancer's Lasting Financial Burden: Evidence From a Longitudinal Assessment

JNCI : Journal of the National Cancer Institute, 2022-07, Vol.114 (7), p.1020-1028

2022

Volltextzugriff (PDF)

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

International journal of radiation oncology, biology, physics, 2020-07, Vol.107 (4), p.631-640

2020

Volltextzugriff (PDF)

Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations

Nature biotechnology, 2022-07, Vol.40 (7), p.1030-1034

2022

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaFemale

ThemaLife Sciences & Biomedicine

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(183)

Publikationsform

Artikel
(203)
Buchkapitel
(2)

Sprache

Englisch
(205)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Humans
(121)
Tumors
(39)
Biological And Medical Sciences
(36)
Animals
(34)
Medical Sciences
(33)
Male
(30)
Radiology, Nuclear Medicine & Medical Imaging
(30)
Cancer
(22)
Mice
(21)
Patients
(21)
Immunotherapy
(18)
Aged
(16)
Middle Aged
(16)
Medicine
(15)
Medicine & Public Health
(14)
Prostatic Neoplasms - Pathology
(14)
Cell Biology
(13)

13 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal

Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy

Combination of photodynamic therapy (PDT) and melphalan in experimental tumors

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach

Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non–Small Cell Lung Cancer

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma

A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients

Clinic-based interventions for improving access to care: a good start

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

Shared acquired genomic changes in zebrafish and human T-ALL

The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

The primary cilium in cell signaling and cancer

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Cancer's Lasting Financial Burden: Evidence From a Longitudinal Assessment

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations

Aktive Filter

Suchergebnisse filtern